Answers are grounded in this paper and cite their sources.
Cladribine, a selective immune reconstitution therapy, is approved for the treatment of adult patients with highly active multiple sclerosis (MS).
No takes yet. Share an insight, caveat, or question.
Potužník et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: